BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2014
View Archived Issues
Enanta Pharma CEO describes company outlook at J.P. Morgan Healthcare Conference
Read More
MAGED4 associated with progression of squamous cell carcinoma of the esophagus
Read More
Genentech and Xenon Pharmaceuticals patent novel sodium channel blockers
Read More
New monospecific HLA-E antibodies described by The Terasaki Family Foundation
Read More
Novel endothelial lipase inhibitors synthesized by Bristol-Myers Squibb
Read More
Takeda Pharmaceutical designs novel PI3Kdelta inhibitors
Read More
Korean researchers present new fusion proteins for diabetes
Read More
Immune Design treats first patient in phase I trial of IDG-100
Read More
Pfizer reports topline data from two phase III trials of dacomitinib in NSCLC
Read More
Sirona Biochem signs licensing agreement with Wanbang Biopharmaceuticals
Read More
DENND2D identified as a biomarker of esophageal cancer prognosis
Read More
Bristol-Myers Squibb reviews activity of fourth quarter 2013
Read More
Progen commences phase I trial of anticancer candidate in Australia
Read More
Enrollment completed in phase III trial of CTI's anticancer agent Opaxio
Read More
FOB Synthesis and AstraZeneca sign option and license agreement for novel antibiotics
Read More
Teva Pharmaceutical launches phase III trial of allogeneic MPCs in chronic heart failure
Read More
Adenovir Pharma initiates phase II study of antiviral drug for infectious eye disease
Read More
Metabolic Pharmaceuticals licenses AOD-9604 to Australian Custom Pharmaceuticals
Read More
Phase I trial to evaluate IGN-523 in acute myeloid leukemia
Read More
Celsion discloses new phase III overall survival data supporting continued development of ThermoDox
Read More
Neuren provides update on phase II trials of NNZ-2566 in four separate neurological disorders
Read More
Sosei transfers Japanese marketing authorization for emergency contraceptive to ASKA
Read More
Galectin Therapeutics and SBH Sciences form new venture to develop oral galectin inhibitors
Read More
Two-herb traditional Chinese medicine proves beneficial for diabetic foot ulcers
Read More
Specific PIPT inhibitors synthesized for interference with phosphoinositide signaling
Read More